researchers examined 1,714 samples over six months and found that just 39 per cent contained what they buyer thought they had been sold
may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..
the staff's "dearth of knowledge" about the correct procedure to follow when someone dies unexpectedly was also highlighted..